Please login to the form below

Not currently logged in
Email:
Password:

Purdue Pharma appoints Dr Alan Dunton

He joins the pain specialist as senior VP of research and development

Purdue Pharma Dr Alan DuntonPurdue Pharma has appointed Dr Alan Dunton as senior vice president of research and development in a role that also sees him join its executive committee.

Dr Dunton will serve as the company's lead scientist and oversee medical research, drug safety, clinical pharmacology, virtual discovery, project management, and pharmaceutics and analytics teams.

He will report to chief executive officer Mark Timney who said: "At a time of transformation for Purdue, Alan brings the right skills and

experience to diversify and grow our portfolio."

Dr Dunton has spent 33 years in the industry discovering and developing new prescription and over-the-counter products. In 2006, he

founded Danerius, a biotechnology and pharmaceutical consulting business, which he led until joining Purdue. 

Prior to starting Danerius, Dr. Dunton held executive-level positions in the pharmaceutical and biotechnology industries, including President and Chief Executive Officer of Panacos Pharmaceuticals and Metaphore Pharmaceuticals.

He was also the president and managing director of the Janssen Research Foundation, the R&D arm of the pharmaceuticals division at Johnson & Johnson.

7th December 2015

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcircle

We're Healthcircle – an award-winning healthcare advertising and creative communications agency, offering a holistic approach to brand health. With a...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics